Correlation between different methods for the semi-quantitative assessment of fluorodeoxyglucose uptake on positron emission tomography scan (FDG-PET), and clinical/hysto-pathological features of Non Small Cell Lung Cancer (NSCLC).

被引：0
|
作者：
Pelosi, E. [1 ]
Skanjeti, A. [2 ]
Bille, A. [3 ]
Arena, V. [1 ]
Errico, L. [2 ]
Penna, D. [2 ]
Mancini, M. [1 ]
机构：
[1] IRMET PET Ctr, Turin, Italy
[2] Univ Turin, Dept Internal Med, Nucl Med Unit, Turin, Italy
[3] Univ Turin, Dept Clin & Biol Sci, Thorac Surg Unit, Turin, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [31] The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer
    Miyasaka, Yoshikazu
    Suzuki, Kenji
    Takamochi, Kazuya
    Matsunaga, Takeshi
    Oh, Shiaki
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 44 (01) : 83 - 87
  • [32] Pathological Stage IIIA, pN2 Non-Small Cell Lung Cancer (NSCLC) With Staging 18-FDG Positron Emission Tomography (PET): Is There a Role for Adjuvant Radiation Therapy (ART)?
    Choong, E. S.
    Yang, J.
    Kennedy, C.
    Tse, R. V.
    Boyer, M.
    McCaughan, B.
    Tin, M. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E488 - E488
  • [33] Positron Emission Tomography (PET) radiotracers in oncology - utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
    Miele, Evelina
    Spinelli, Gian Paolo
    Tomao, Federica
    Zullo, Angelo
    De Marinis, Filippo
    Pasciuti, Giulia
    Rossi, Luigi
    Zoratto, Federica
    Tomao, Silverio
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2008, 27 (1)
  • [34] Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
    Evelina Miele
    Gian Paolo Spinelli
    Federica Tomao
    Angelo Zullo
    Filippo De Marinis
    Giulia Pasciuti
    Luigi Rossi
    Federica Zoratto
    Silverio Tomao
    Journal of Experimental & Clinical Cancer Research, 27
  • [35] ASSOCIATION BETWEEN PULMONARY UPTAKE OF FLUORODEOXYGLUCOSE DETECTED BY POSITRON EMISSION TOMOGRAPHY SCANNING AFTER RADIATION THERAPY FOR NON-SMALL-CELL LUNG CANCER AND RADIATION PNEUMONITIS
    Mac Manus, Michael P.
    Ding, Zhe
    Hogg, Annette
    Herschtal, Alan
    Binns, David
    Ball, David L.
    Hicks, Rodney J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (05): : 1365 - 1371
  • [36] Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome
    Romine, Perrin E.
    Martins, Renato G.
    Eaton, Keith D.
    Wood, Douglas E.
    Behnia, Fatemeh
    Goulart, Bernardo H. L.
    Mulligan, Michael S.
    Wallace, Sarah G.
    Kell, Elizabeth
    Bauman, Julie E.
    Patel, Shilpen A.
    Vesselle, Hubert J.
    BMC CANCER, 2019, 19 (1)
  • [37] Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome
    Perrin E. Romine
    Renato G. Martins
    Keith D. Eaton
    Douglas E. Wood
    Fatemeh Behnia
    Bernardo H. L. Goulart
    Michael S. Mulligan
    Sarah G. Wallace
    Elizabeth Kell
    Julie E. Bauman
    Shilpen A. Patel
    Hubert J. Vesselle
    BMC Cancer, 19
  • [38] Comparison of primary tumor maximal standardized uptake value (SUVmax) on preoperative [18F] fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and histological subtype in patients with non-small cell lung cancer (NSCLC)
    Davidson, J. A.
    Wong, V.
    Fraser, R.
    Hirsh, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Usefulness of 18FDG-positron emission tomografy (FDG-PET) for early prediction of erlotinib (Eb) tratment outcome in non-small cell lung cancer (NSCLC) patients: Result of a pilot study.
    Ippolito, M.
    Bordonaro, R.
    Tiseo, M.
    Cosentino, S.
    Mure, G.
    Baldari, S.
    Ardizzoni, A.
    Ruffini, L.
    Latteri, F.
    Spadaro, P.
    Parra, H. Soto
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S250 - S250
  • [40] Has primary tumour standardized maximum uptake value (SUV max) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) a prognostic value for survival in nonsmall cell lung cancer (NSCLC) ? A systematic review and metaanalysis (MA) by the European Lung Cancer Working Party for the IASLC Staging Project
    Paesmans, Marianne
    Dusart, Michelle
    Berghmans, Thierry
    Hossein-Foucher, Claude
    Castaigne, Catherine
    Scherpereel, Arnaud
    Mascaux, Celine
    Moreau, Michel
    Roelandts, Martine
    Alard, Stephane
    Meert, Anne-Pascale
    Lafitte, Jean-Jacques
    Patz, Ned
    Sculier, Jean-Paul
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S313 - S314
12345